816 results on '"Ramjee, Gita"'
Search Results
102. Response to Brown et al., ‘Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe’
103. Sodium dodecyl sulphate polyacrylamide gel electrophoresis of urinary proteins in steroid-responsive and steroid-resistant nephrotic syndrome in children
104. Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women
105. Temporal trends in sexual behaviours and their impacts on HIV incidence among South African women: 2002–2016.
106. Biological impact of recurrent sexually transmitted infections on HIV seroconversion among women in South Africa: results from frailty models
107. Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations
108. Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
109. Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world
110. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers
111. Evaluation of a health system intervention to improve virological management in an antiretroviral programme at a municipal clinic in central Durban
112. OC 8491 PREPVACC: A PHASE III, MAMS ADAPTIVE PROPHYLACTIC HIV VACCINE TRIAL WITH A SECOND RANDOMISATION TO COMPARE F/TAF WITH TDF/FTC PREP
113. Correlates of Sexually Transmitted Infections Among South African Women Using Individual- and Community-Level Factors: Results from Generalized Additive Mixed Models
114. Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
115. Geoadditive models to assess spatial variation of HIV infections among women in Local communities of Durban, South Africa
116. Geographical-level contributions of risk factors for HIV infections using generalized additive models: results from a cohort of South African women
117. Anal Sex and HIV Transmission in Women
118. Unrecognized genital ulcer disease among rural South African women
119. Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa
120. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial
121. A developing country response to Lavery et al. 'In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?'
122. Comparison of noninvasive methods for distinguishing steroid-sensitive nephrotic syndrome from focal glomerulosclerosis
123. Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
124. Microbicides 2008 conference: From discovery to advocacy
125. Direct and indirect tests of pore size and charge selectivity in nephrotic syndrome
126. Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa
127. Perceptions of vaginal microbicides as an HIV prevention method among health care providers in KwaZulu-Natal, South Africa
128. Microbicides 2006 conference
129. Evaluating HIV prevention efforts using semiparametric regression models: results from a large cohort of women participating in an HIV prevention trial from Kwazulu-Natal, South Africa
130. Food insecurity, HIV status and prior testing at South African primary healthcare clinics
131. Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa
132. Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial
133. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
134. Cohort effects on sexual behavior and risk of acquisition of sexually transmitted infections and HIV in a South African HIV prevention trial
135. Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel
136. PIMATM point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa
137. Oral and injectable contraceptive use and HIV acquisition risk among women in 4 African countries: a secondary analysis of data from a microbicide trial
138. Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa
139. Study protocol for a longitudinal study evaluating the impact of rape on women’s health and their use of health services in South Africa
140. Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early in blood and tissue
141. “I did not see a need to get tested before, everything was going well with my health”: a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa
142. HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial
143. Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care
144. Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring.
145. Geographical-level contributions of risk factors for HIV infections using generalized additive models: results from a cohort of South African women.
146. Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection
147. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
148. Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial
149. The generational effect on age disparate partnerships and the risk for human immunodeficiency virus and sexually transmitted infections acquisition
150. Prevalent bacterial vaginosis infection – a risk factor for incident sexually transmitted infections in women in Durban, South Africa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.